Pharmazz, Inc. — SEC Form D Filing

Pharmazz, Inc. filed an SEC Form D on July 28, 2026, reporting $250K raised in Pharmaceuticals.

Form D filing details

Filing
SEC Form D
Filing date
July 28, 2026
Amount reported
$250K
Round stage
Seed
Industry
Pharmaceuticals
Website
https://pharmazz.com

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Pharmaceutical companies face challenges in developing and bringing new drugs to market efficiently and cost-effectively, often due to complex research, development, and regulatory hurdles.

Solution

Pharmazz, Inc. provides specialized contract research and development services, including preclinical testing, clinical trial management, and regulatory consulting, to accelerate drug discovery and approval for other pharmaceutical businesses.

Why now

The specific timing catalyst for Pharmazz is unclear from available information.

Source: SEC EDGAR Form D filing